Neuroprotective Natural Products for the Treatment of Parkinson's Disease by Targeting the Autophagy-Lysosome Pathway: A Systematic Review

被引:41
作者
Wang, Zi-Ying [1 ,2 ]
Liu, Jing-Yi [1 ,2 ]
Yang, Chuan-Bin [1 ,2 ]
Malampati, Sandeep [1 ,2 ]
Huang, Ying-Yu [1 ,2 ]
Li, Mei-Xiang [1 ,2 ]
Li, Min [1 ]
Song, Ju-Xian [1 ]
机构
[1] Hong Kong Baptist Univ, Sch Chinese Med, Kowloon, Hong Kong, Peoples R China
[2] Hong Kong Baptist Univ, Mr & Mrs Ko Chi Ming Ctr Parkinsons Dis Res, Kowloon, Hong Kong, Peoples R China
关键词
Parkinson's disease; autophagy; neuroprotection; natural products; UBIQUITIN-PROTEASOME SYSTEM; ALPHA-SYNUCLEIN; RAT MODEL; NEURODEGENERATIVE DISEASES; OXIDATIVE STRESS; CELLULAR-MODELS; DOWN-REGULATION; SH-SY5Y CELLS; MTOR; DEGRADATION;
D O I
10.1002/ptr.5834
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The autophagy-lysosome pathway (ALP) is a primary means by which damaged organelles and long-lived proteins are removed from cells and their components recycled. Impairment of the ALP has been found to be linked to the pathogenesis of Parkinson's disease (PD), a chronic neurodegenerative disorder characterized by the accumulation of protein aggregates and loss of dopaminergic neurons in the midbrain. In recent years, some active compounds derived from plants have been found to regulate the ALP and to exert neuroprotective effects in experimental models of PD, raising the possibility that autophagy enhancement may be an effective therapeutic strategy in PD treatment. In this review, we summarize recent findings of natural products that enhance ALP and thereby protect against PD. Research articles were retrieved from PubMed using relevant keywords in combination. Papers related to the topic were identified, and then the reliability of the experiments was assessed in terms of methodology. The results suggest that targeting the ALP with natural products is a promising strategy for PD treatment. However, risk of bias exists in some studies due to the defective methodology. Rigorous experimental design following the guidelines of autophagy assays, molecular target identification and in vivo efficacy evaluation is critical for the development of ALP enhancers for PD treatment in future studies. Copyright (C) 2017 John Wiley & Sons, Ltd.
引用
收藏
页码:1119 / 1127
页数:9
相关论文
共 82 条
  • [1] [Anonymous], BR J PHARM
  • [2] Pharmacological prevention of Parkinson disease in Drosophila
    Auluck, PK
    Bonini, NM
    [J]. NATURE MEDICINE, 2002, 8 (11) : 1185 - 1186
  • [3] Autophagy in neurodegenerative disorders: pathogenic roles and therapeutic implications
    Banerjee, Rebecca
    Beal, M. Flint
    Thomas, Bobby
    [J]. TRENDS IN NEUROSCIENCES, 2010, 33 (12) : 541 - 549
  • [4] Cai Zhiyou, 2013, J Biochem Pharmacol Res, V1, P84
  • [5] Pharmaceutical screen identifies novel target processes for activation of autophagy with a broad translational potential
    Chauhan, Santosh
    Ahmed, Zahra
    Bradfute, Steven B.
    Arko-Mensah, John
    Mandell, Michael A.
    Choi, Seong Won
    Kimura, Tomonori
    Blanchet, Fabien
    Waller, Anna
    Mudd, Michal H.
    Jiang, Shanya
    Sklar, Larry
    Timmins, Graham S.
    Maphis, Nicole
    Bhaskar, Kiran
    Piguet, Vincent
    Deretic, Vojo
    [J]. NATURE COMMUNICATIONS, 2015, 6
  • [6] Corynoxine, a Natural Autophagy Enhancer, Promotes the Clearance of Alpha-Synuclein via Akt/mTOR Pathway
    Chen, Lei-Lei
    Song, Ju-Xian
    Lu, Jia-Hong
    Yuan, Zhen-Wei
    Liu, Liang-Feng
    Durairajan, Siva Sundara Kumar
    Li, Min
    [J]. JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2014, 9 (03) : 380 - 387
  • [7] Choi AMK, 2013, NEW ENGL J MED, V368, P1845, DOI [10.1056/NEJMra1205406, 10.1056/NEJMc1303158]
  • [8] Parkinson's disease: Mechanisms and models
    Dauer, W
    Przedborski, S
    [J]. NEURON, 2003, 39 (06) : 889 - 909
  • [9] TFEB-mediated autophagy rescues midbrain dopamine neurons from α-synuclein toxicity
    Decressac, Mickael
    Mattsson, Bengt
    Weikop, Pia
    Lundblad, Martin
    Jakobsson, Johan
    Bjorklund, Anders
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 110 (19) : E1817 - E1826
  • [10] Pathogenic Lysosomal Depletion in Parkinson's Disease
    Dehay, Benjamin
    Bove, Jordi
    Rodriguez-Muela, Natalia
    Perier, Celine
    Recasens, Ariadna
    Boya, Patricia
    Vila, Miquel
    [J]. JOURNAL OF NEUROSCIENCE, 2010, 30 (37) : 12535 - 12544